Author:
Perumal Kokila Vani,Bahari Hasnah,Shari NorShafarina,Kanniappan Kasturi,Abdul Kadir Khairul Kamilah,Abdullah Zunoliza,Ahmad Mohd Radzi,Kwaifa Ibrahim Kalle,Jumidil Siti Hadizah,Zainal Abidin Azrina,Md Noor Sabariah,Yong Yoke Keong,Balan Santhra Segaran
Abstract
Introduction: The incidence and complications of hyperlipidemia associated co-morbidities and mortalities are grossly increasing globally. Intervention with natural products preparation has been identified as an alternative for the management of hyperlipidaemia and its related cardiovascular complications. This study investigated the anti-hyperlipidaemic activities of a mixture of Zinger officinale, Allium sativum, Citrus lemon, honey, and Malus domestica vinegar (ZACAH) extracts in in Sprague Dawley (SD) rats fed with high cholesterol diet. Methods: Thirty-six male SD rats were randomly distributed into 6 groups, including normal chow diet-fed (NC), high cholesterol diet (HCD), HCD+ Simvastatin (standard drug) while the remaining three groups were fed with HCD + ZACAH extracts at different doses (1, 3 and 5mg/kg body weight) for 18 weeks. Simvastatin at 10 mg/kg of bodyweight was used as control. High-performance liquid chromatography (HPLC) was used to determine phenolic compounds present in ZACAH extracts, elastase inhibitory assay was determined using spectrometric with a substrate (N-Succ-(Ala)3-pnitroanilide (SANA) while 2,2-diphenyl-1-picrylhydrazyl (DPPH) was performed based by the method described by Blois, 1958. Results: In vitro; ZACAH extracts had oxygen radical absorbance capacity (ORAC) value of 2000 µmol TE/100 mL, total phenolic content (TPC) of 7537 ± 54.5%, DPPH free radical scavenging activity of 27.34 ± 2.71%, elastase inhibitory assay of 29.29 ± 1.65% and lipoxygenase inhibitory assay of 98.58 ± 1.42%. In vivo, ZACAH extracts showed decreased bodyweight, adipose tissue, improved lipid profiles and hepatic biochemical enzymes. Conclusion: These results suggested that ZACAH extracts supplementation improved hyperlipidaemia in SD rats and might be a promising adjuvant for the treatment of hyperlipidaemia.
Publisher
Universiti Putra Malaysia
Reference38 articles.
1. 1. Karam I, Yang YJ, Li JY. Hyperlipidemia Background and Progress. SM Atherosclerosis Journal. 2017; 1(1): 1–8.
2. 2. Chen J, Deng J, Zhang Y, Yang J, He Y, Fu W, Xing P, tong Wan H. Lipid-lowering effects of Danhong injection on hyperlipidemia rats. Journal of ethnopharmacology. 2014 Jun 11;154(2):437-42. doi: 10.1016/j.jep.2014.04.023
3. 3. World Health Organization (2020). Raised cholesterol- Global health Obsevatory (GHO) data. Available at: http://apps.who.int/gb/NCDs/pdf/A_NCD_2-en.pdf
4. 4. Han Q, Yeung SC, Ip MS, Mak JC. Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids in health and disease. 2018 Dec;17(1):1-0. doi: 10.1186/s12944-018-0905-3.
5. 5. Weibel GL, Drazul-Schrader D, Shivers DK, Wade AN, Rothblat GH, Reilly MP, et al. Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2014 Jan;34(1):17-25. doi: 10.1161/ATVBAHA.113.302437.